Advanced search
Publication Cover
Leukemia & Lymphoma Volume 61, 2020 - Issue 3
Submit an article Journal homepage
5,080
Views
5
CrossRef citations to date
0
Altmetric
Original Articles

Relative efficacy of treatment options in transplant-ineligible newly diagnosed multiple myeloma: results from a systematic literature review and network meta-analysis

Karthik RamasamyNational Institute for Health Research, Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK; Correspondence[email protected]
View further author information
,
Sujith DhanasiriCelgene International, Boudry, Switzerland; View further author information
,
Howard ThomBristol Medical School, University of Bristol, Bristol, UK; View further author information
,
Vanessa BuchananCogentia Healthcare Consulting Ltd, Cambridge, UK; View further author information
,
Suzanne RobinsonCelgene International, Boudry, Switzerland; View further author information
,
Vijay K. D’SouzaCogentia Healthcare Consulting Ltd, Cambridge, UK; View further author information
&
Katja WeiselDepartment of Oncology, Hematology and Bone Marrow Transplantation with Section of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, GermanyView further author information
 show all
Pages 668-679 | Received 07 May 2019, Accepted 13 Oct 2019, Published online: 11 Nov 2019

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Pellegrino Musto & Francesco La Rocca. (2020) Monoclonal antibodies in newly diagnosed and smoldering multiple myeloma: an updated review of current clinical evidence. Expert Review of Hematology 13:5, pages 501-517.
Read now
Iuliana Vaxman & Morie Gertz. (2020) Non-transplant eligible multiple myeloma: deciphering optimal first line regimens. Leukemia & Lymphoma 61:3, pages 504-506.
Read now

Articles from other publishers (3)

Georgia J. McCaughan, Sara Gandolfi, John J. Moore & Paul G. Richardson. (2022) Lenalidomide, bortezomib and dexamethasone induction therapy for the treatment of newly diagnosed multiple myeloma: a practical review. British Journal of Haematology 199:2, pages 190-204.
Crossref
Bruno Almeida Costa, Tarek H. Mouhieddine & Joshua Richter. (2022) What’s Old is New: The Past, Present and Future Role of Thalidomide in the Modern-Day Management of Multiple Myeloma. Targeted Oncology 17:4, pages 383-405.
Crossref
Thierry Facon, Jesús San-Miguel, Meletios A. Dimopoulos, Maria-Victoria Mateos, Michele Cavo, Sophie van Beekhuizen, Zijiao Yuan, João Mendes, Annette Lam, Jianming He, Eric Ammann & Shaji Kumar. (2022) Treatment Regimens for Transplant-Ineligible Patients With Newly Diagnosed Multiple Myeloma: A Systematic Literature Review and Network Meta-analysis. Advances in Therapy 39:5, pages 1976-1992.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.